Cheryl
Reicin

Partner at Torys LLP | Chair of Life Sciences Practice

Brief Bio:

Cheryl is the practice leader of Torys’ Life Science Group, a cross-border group in both Canada and New York. Cheryl represents the whole spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers. She advises companies, in joint ventures and licensing transactions, financing and mergers and acquisitions throughout the world. Cheryl assists companies in formulating domestic and international growth strategies and in sourcing capital. She advises on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She also coordinates domestic and international structuring, intellectual property planning and regulatory strategy. Cheryl is a four-time awardee of WXN’s Canada’s Top 100 Most Powerful Women and is a member of that organization’s Hall of Fame. Prior to joining Torys, Cheryl led the 85-attorney life science group of a U.S. law firm.

Research Interests:

Affiliations:

Site:

https://www.torys.com/people/reicin-cheryl-v

"The translational paradigm of the TRP has revolutionized my thinking.”

 - Dr Clyde M.